ITRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Itron Inc is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is trading near 85.08 with only a slight daily move, technicals are neutral-to-mildly positive, and analyst sentiment is mixed after recent target cuts. With no fresh news catalyst and no strong proprietary buy signal, the best call today is to hold rather than buy aggressively.
The trend is constructive but not decisive. MACD histogram is positive at 0.642, but it is contracting, which suggests momentum is cooling. RSI_6 at 63.4 is neutral, leaning mildly bullish but not overextended. Moving averages are converging, signaling consolidation rather than a clear breakout trend. Price is currently just above the pivot at 83.762 and below first resistance at 87.257. That places the stock in the middle of a short-term range, not at an obvious high-conviction entry. The modeled stock trend suggests a modest upside bias over the next day, week, and month, but not enough to justify a strong buy on its own.
["Analyst firms such as TD Cowen, Roth Capital, Baird, Oppenheimer, and JPMorgan still maintain Buy/Outperform/Overweight-type ratings despite lowering targets.", "TD Cowen noted 1Q26 results beat expectations and grid-edge technology deployment remains on track.", "Roth Capital expects asset-light transition benefits to continue supporting margins and sentiment.", "Oppenheimer cited stronger electrification demand and improving microgrid economics.", "JPMorgan highlighted a catalyst-rich environment tied to data center announcements and order volumes."]
["Several analysts lowered price targets, showing reduced near-term upside expectations.", "Raymond James resumed coverage with an Underperform rating and argued the business is normalizing after unusually strong deployments in 2024.", "Q2 guidance was below expectations according to analyst commentary.", "No recent news in the last week means no fresh catalyst to re-rate the stock.", "Hedge funds and insiders are both neutral, with no notable buying signal.", "No recent congress trading data and no politician/influential figure trading activity were reported."]
No latest-quarter financial statement data was available because the financial snapshot returned an error, so there is no verified revenue, EPS, or margin detail to assess directly. Based on analyst commentary, 1Q26 appears to have beaten expectations, but the follow-through for 2Q26 was weaker than expected. That implies the latest quarter season was likely stronger than the upcoming quarter guidance, which points to slowing near-term growth momentum rather than acceleration.
Recent analyst action is mixed but still leaning positive overall. Multiple firms kept Buy/Outperform/Overweight ratings while cutting price targets: TD Cowen to $130 from $145, Roth Capital to $136 from $150, Baird to $118 from $128, Oppenheimer raised its target slightly to $135 from $133 and kept Outperform, and JPMorgan lowered to $113 from $133 while keeping Overweight. The main bearish note came from Raymond James, which initiated/resumed coverage with Underperform and said the stock could be worth about 30% below current prices. Wall Street's pros view is that Itron has strong exposure to grid-edge, electrification, and data-center-driven demand with improving margins. The cons view is that near-term growth is moderating, deployment normalization may last longer than expected, and recent guidance suggests slower momentum ahead.
